Logo image of MDT

MEDTRONIC PLC (MDT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MDT - IE00BTN1Y115 - Common Stock

98.69 USD
-1.08 (-1.08%)
Last: 1/8/2026, 7:22:07 PM
99.3 USD
+0.61 (+0.62%)
After Hours: 1/8/2026, 7:22:07 PM
Fundamental Rating

6

MDT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. While MDT has a great profitability rating, there are some minor concerns on its financial health. MDT has a decent growth rate and is not valued too expensively. MDT also has an excellent dividend rating. With these ratings, MDT could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MDT was profitable.
In the past year MDT had a positive cash flow from operations.
In the past 5 years MDT has always been profitable.
In the past 5 years MDT always reported a positive cash flow from operatings.
MDT Yearly Net Income VS EBIT VS OCF VS FCFMDT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

The Return On Assets of MDT (5.22%) is better than 81.62% of its industry peers.
The Return On Equity of MDT (9.79%) is better than 85.41% of its industry peers.
MDT has a Return On Invested Capital of 6.63%. This is amongst the best in the industry. MDT outperforms 81.08% of its industry peers.
MDT had an Average Return On Invested Capital over the past 3 years of 6.35%. This is below the industry average of 8.84%.
The 3 year average ROIC (6.35%) for MDT is below the current ROIC(6.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROIC 6.63%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
MDT Yearly ROA, ROE, ROICMDT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 13.71%, MDT belongs to the best of the industry, outperforming 89.73% of the companies in the same industry.
MDT's Profit Margin has declined in the last couple of years.
MDT's Operating Margin of 19.42% is amongst the best of the industry. MDT outperforms 92.97% of its industry peers.
In the last couple of years the Operating Margin of MDT has remained more or less at the same level.
The Gross Margin of MDT (65.57%) is better than 69.73% of its industry peers.
MDT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
MDT Yearly Profit, Operating, Gross MarginsMDT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDT is creating some value.
MDT has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MDT has less shares outstanding
MDT has a worse debt/assets ratio than last year.
MDT Yearly Shares OutstandingMDT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
MDT Yearly Total Debt VS Total AssetsMDT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 3.10 indicates that MDT is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.10, MDT is doing good in the industry, outperforming 69.19% of the companies in the same industry.
MDT has a debt to FCF ratio of 5.59. This is a neutral value as MDT would need 5.59 years to pay back of all of its debts.
The Debt to FCF ratio of MDT (5.59) is better than 78.38% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that MDT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.57, MDT is doing worse than 61.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Altman-Z 3.1
ROIC/WACC1
WACC6.62%
MDT Yearly LT Debt VS Equity VS FCFMDT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 2.42 indicates that MDT has no problem at all paying its short term obligations.
The Current ratio of MDT (2.42) is comparable to the rest of the industry.
A Quick Ratio of 1.80 indicates that MDT should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.80, MDT is in line with its industry, outperforming 48.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 1.8
MDT Yearly Current Assets VS Current LiabilitesMDT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.24% over the past year.
Measured over the past 5 years, MDT shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
The Revenue has been growing slightly by 5.34% in the past year.
Measured over the past years, MDT shows a small growth in Revenue. The Revenue has been growing by 3.01% on average per year.
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%

3.2 Future

Based on estimates for the next years, MDT will show a small growth in Earnings Per Share. The EPS will grow by 6.35% on average per year.
MDT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.79% yearly.
EPS Next Y3.64%
EPS Next 2Y6%
EPS Next 3Y6.38%
EPS Next 5Y6.35%
Revenue Next Year7.65%
Revenue Next 2Y6.76%
Revenue Next 3Y6.25%
Revenue Next 5Y5.79%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MDT Yearly Revenue VS EstimatesMDT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
MDT Yearly EPS VS EstimatesMDT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

MDT is valuated rather expensively with a Price/Earnings ratio of 17.53.
Based on the Price/Earnings ratio, MDT is valued cheaply inside the industry as 84.86% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MDT to the average of the S&P500 Index (27.00), we can say MDT is valued slightly cheaper.
The Price/Forward Earnings ratio is 15.97, which indicates a correct valuation of MDT.
Based on the Price/Forward Earnings ratio, MDT is valued cheaper than 87.57% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MDT to the average of the S&P500 Index (23.70), we can say MDT is valued slightly cheaper.
Industry RankSector Rank
PE 17.53
Fwd PE 15.97
MDT Price Earnings VS Forward Price EarningsMDT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MDT is valued cheaply inside the industry as 82.70% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MDT is valued cheaper than 84.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.3
EV/EBITDA 14.5
MDT Per share dataMDT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
MDT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.82
PEG (5Y)4.76
EPS Next 2Y6%
EPS Next 3Y6.38%

7

5. Dividend

5.1 Amount

MDT has a Yearly Dividend Yield of 2.96%.
Compared to an average industry Dividend Yield of 0.20, MDT pays a better dividend. On top of this MDT pays more dividend than 98.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, MDT pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.96%

5.2 History

The dividend of MDT has a limited annual growth rate of 5.10%.
MDT has paid a dividend for at least 10 years, which is a reliable track record.
MDT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.1%
Div Incr Years11
Div Non Decr Years11
MDT Yearly Dividends per shareMDT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

MDT pays out 75.86% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP75.86%
EPS Next 2Y6%
EPS Next 3Y6.38%
MDT Yearly Income VS Free CF VS DividendMDT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MDT Dividend Payout.MDT Dividend Payout, showing the Payout Ratio.MDT Dividend Payout.PayoutRetained Earnings

MEDTRONIC PLC

NYSE:MDT (1/8/2026, 7:22:07 PM)

After market: 99.3 +0.61 (+0.62%)

98.69

-1.08 (-1.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-18 2025-11-18/bmo
Earnings (Next)02-17 2026-02-17/bmo
Inst Owners88.22%
Inst Owner Change0%
Ins Owners0.28%
Ins Owner Change3.68%
Market Cap126.52B
Revenue(TTM)34.76B
Net Income(TTM)4.76B
Analysts73.33
Price Target112.26 (13.75%)
Short Float %1.18%
Short Ratio2.22
Dividend
Industry RankSector Rank
Dividend Yield 2.96%
Yearly Dividend2.77
Dividend Growth(5Y)5.1%
DP75.86%
Div Incr Years11
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.96%
Min EPS beat(2)1.49%
Max EPS beat(2)2.43%
EPS beat(4)4
Avg EPS beat(4)1.68%
Min EPS beat(4)1.21%
Max EPS beat(4)2.43%
EPS beat(8)6
Avg EPS beat(8)1.26%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)10
Avg EPS beat(16)1.24%
Revenue beat(2)2
Avg Revenue beat(2)0.49%
Min Revenue beat(2)0.08%
Max Revenue beat(2)0.91%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)0.91%
Revenue beat(8)7
Avg Revenue beat(8)0.29%
Revenue beat(12)10
Avg Revenue beat(12)0.59%
Revenue beat(16)11
Avg Revenue beat(16)-0.1%
PT rev (1m)8.82%
PT rev (3m)11.63%
EPS NQ rev (1m)-0.08%
EPS NQ rev (3m)-1.21%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 17.53
Fwd PE 15.97
P/S 3.64
P/FCF 24.3
P/OCF 17.79
P/B 2.6
P/tB N/A
EV/EBITDA 14.5
EPS(TTM)5.63
EY5.7%
EPS(NY)6.18
Fwd EY6.26%
FCF(TTM)4.06
FCFY4.11%
OCF(TTM)5.55
OCFY5.62%
SpS27.11
BVpS37.95
TBVpS-3.06
PEG (NY)4.82
PEG (5Y)4.76
Graham Number69.34
Profitability
Industry RankSector Rank
ROA 5.22%
ROE 9.79%
ROCE 8.29%
ROIC 6.63%
ROICexc 7.39%
ROICexgc 26.33%
OM 19.42%
PM (TTM) 13.71%
GM 65.57%
FCFM 14.98%
ROA(3y)4.43%
ROA(5y)4.54%
ROE(3y)8.11%
ROE(5y)8.19%
ROIC(3y)6.35%
ROIC(5y)6.24%
ROICexc(3y)7.09%
ROICexc(5y)7.05%
ROICexgc(3y)29.85%
ROICexgc(5y)33.32%
ROCE(3y)7.94%
ROCE(5y)7.8%
ROICexgc growth 3Y-11.61%
ROICexgc growth 5Y-5.52%
ROICexc growth 3Y-2.49%
ROICexc growth 5Y3.26%
OM growth 3Y-3.47%
OM growth 5Y0.37%
PM growth 3Y-4.39%
PM growth 5Y-3.44%
GM growth 3Y-1.55%
GM growth 5Y-0.76%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 5.59
Debt/EBITDA 2.83
Cap/Depr 63.21%
Cap/Sales 5.49%
Interest Coverage 8.53
Cash Conversion 72.83%
Profit Quality 109.28%
Current Ratio 2.42
Quick Ratio 1.8
Altman-Z 3.1
F-Score8
WACC6.62%
ROIC/WACC1
Cap/Depr(3y)59.68%
Cap/Depr(5y)55.94%
Cap/Sales(3y)5.04%
Cap/Sales(5y)4.79%
Profit Quality(3y)124.85%
Profit Quality(5y)125.74%
High Growth Momentum
Growth
EPS 1Y (TTM)7.24%
EPS 3Y-0.72%
EPS 5Y3.68%
EPS Q2Q%7.94%
EPS Next Y3.64%
EPS Next 2Y6%
EPS Next 3Y6.38%
EPS Next 5Y6.35%
Revenue 1Y (TTM)5.34%
Revenue growth 3Y1.91%
Revenue growth 5Y3.01%
Sales Q2Q%6.64%
Revenue Next Year7.65%
Revenue Next 2Y6.76%
Revenue Next 3Y6.25%
Revenue Next 5Y5.79%
EBIT growth 1Y7.35%
EBIT growth 3Y-1.62%
EBIT growth 5Y3.4%
EBIT Next Year16.85%
EBIT Next 3Y10.65%
EBIT Next 5Y9.23%
FCF growth 1Y28.67%
FCF growth 3Y-4.64%
FCF growth 5Y-2.95%
OCF growth 1Y27.68%
OCF growth 3Y-1.39%
OCF growth 5Y-0.53%

MEDTRONIC PLC / MDT FAQ

What is the fundamental rating for MDT stock?

ChartMill assigns a fundamental rating of 6 / 10 to MDT.


What is the valuation status for MDT stock?

ChartMill assigns a valuation rating of 6 / 10 to MEDTRONIC PLC (MDT). This can be considered as Fairly Valued.


What is the profitability of MDT stock?

MEDTRONIC PLC (MDT) has a profitability rating of 8 / 10.


What is the valuation of MEDTRONIC PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDTRONIC PLC (MDT) is 17.53 and the Price/Book (PB) ratio is 2.6.


What is the earnings growth outlook for MEDTRONIC PLC?

The Earnings per Share (EPS) of MEDTRONIC PLC (MDT) is expected to grow by 3.64% in the next year.